본문 바로가기

NOVEL TREATMENT OF FIRST BITE SYNDROME USING BOTULINUM TOXIN TYPE A

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1
피인용
Web of Science 38
JCR IF
JCR 2008 2.603
ISSN
1043-3074

저자

  1. 이병주제1저자부산대학교, 의과대학, 의학과, KO
  2. 이진춘교신저자부산대학교, 의과대학, 의학과, KO
  3. 이영옥부산대학교, 의과대학, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, KO
  4. 왕수건부산대학교, 의과대학, 의학과, KO
  5. 김학진부산대학교, 의과대학, 의학과, 영상의학교실, KO

초록

Background. First bite syndrome is the development of pain in the parotid region after the first bite of each meal and can be seen after surgery of the parapharyngeal space. The purpose of this study is to evaluate the efficacy of intraglandular injection of botulinum toxin type A (BTA) in patients with first bite syndrome. Methods. Five patients with first bite syndrome developed after head and neck surgery were treated by injection of BTA into parotid gland, All patients completed a 4-item quality-of-life survey with a 10-point response scale designed to measure outcome of intraglanbular injection of BTA. Results. The first bite syndrome without or with sialogogue and degree of interference with daily activity with or without eating or drinking improved significantly at 1 and 3 month after injection (p<.05). Conclusion. The BTA injection into affected parotid gland produces a decrease in the severity of first bite syndrome and improves the patient's quality of life. (C) 2009 Wiley Periodicals, Inc. Head Neck 31: 989-993, 2009

키워드

first bite syndromebotulinum toxin type Atreatmentquality of lifeparapharyngeal space massPARAPHARYNGEAL SPACESCHWANNOMAFLOW

식별자

WoS UID
000268529900002